the Effect of Broken Ganoderma Lucidum Spore Powder on Quality of Life and Immune Function in Patients With Diffuse Large B-cell Lymphoma After Chemotherapy
Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Jun 3, 2021
Trial Information
Current as of June 08, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diffuse large B-cell lymphoma,NOS
- • all patients were diagnosed for the first time
- • between 18-75 years old, male and female
- • ECoG 0-3 ,the expected survival was more than 6 months
- • the pregnancy test of women of childbearing age was negative; Male and female patients should agree to take effective contraceptive measures during the treatment period and one year of follow-up;
- • sign the informed consent before the test screening
- Exclusion Criteria:
- • those who are known to be allergic to the study drug or its related components; Or allergic patients
- • uncontrolled psychosis
- • participating in other trials at the same time, and using experimental drugs that may affect the efficacy and safety evaluation
- • impairment of liver and kidney function
- • HIV antibody positive;
- • HBsAg positive hepatitis B carriers and confirmed hepatitis B and C patients;
- • pregnant or lactating women and patients who do not agree to take effective contraceptive measures;
- • the patient is unable to swallow the capsule or has a disease or condition that seriously affects the gastrointestinal function;
About Second Affiliated Hospital, School Of Medicine, Zhejiang University
The Second Affiliated Hospital of Zhejiang University School of Medicine is a leading clinical research institution dedicated to advancing healthcare through innovative medical practices and rigorous scientific inquiry. With a robust infrastructure and a multidisciplinary team of experienced researchers and clinicians, the hospital is committed to conducting high-quality clinical trials that address critical health challenges. As an integral part of Zhejiang University, the hospital leverages academic expertise and cutting-edge technology to foster collaboration in research, education, and patient care, ultimately aiming to improve patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hangzhou, Zhejiang, China
Patients applied
Trial Officials
yun liang
Principal Investigator
2ndAffiliated Hospital, School of Medicine, Zhejiang University, China
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials